Greenlight Re Announces Financial Results for Third Quarter and Nine Months Ended September 30, 2025

Achieves Record Quarterly Underwriting Income, Leading to a Combined Ratio of 86.6% GRAND CAYMAN, Cayman Islands, Nov. 03, 2025 (GLOBE ...

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

Imaging data from the phase 2 MINDFuL trial in Alzheimer’s Disease should be released in Q4 2025. Final data on the INKmune CARE-PC trial is expected in Q4 2025. Financial Results for the Third ...